Ondine Biomedical (LSE:OBI) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical ROE % Adjusted to Book Value?

Ondine Biomedical's ROE % for the quarter that ended in Jun. 2024 was -1,437.29%. Ondine Biomedical's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Ondine Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Ondine Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for Ondine Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical ROE % Adjusted to Book Value Chart

Ondine Biomedical Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-16.82

-11.73

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-11.35	-21.99	-20.59	-23.70	-

Competitive Comparison of Ondine Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Ondine Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Ondine Biomedical ROE % Adjusted to Book Value Calculation

Ondine Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-205.35%	/	17.50
	=	-11.73%

Ondine Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,437.29%	/	N/A
	=	N/A

Ondine Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (LSE:OBI) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VF5:Germany

Address

1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6

Website

https://www.ondinebio.com

Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines